Cathie's Ark LogoCathie's Ark
Trading Floor Community IconFrom the Trading Floor:
Intellia Therapeutics Inc Logo

ARKK Holdings of Intellia Therapeutics (NTLA) - Updated Daily

Lock Icon
Date
Direction
Shares
Fund Weight
Fund
December 2, 2021BUY793360.0493%ARKK
December 1, 2021BUY100ARKK
November 22, 2021BUY1405090.0901%ARKK
November 18, 2021BUY14150.0009%ARKK
November 17, 2021BUY83120.0054%ARKK

Key Statistics

🕵🏼Found In🏷Last Price
ARKKARKG$101.03
⚖️Weighting🧢Market Cap
3.14%$7.52b
🏋🏿‍♂️Weight Rank In ARKK🧮Price to Sales
13280.61
🏋️‍♀️Weight Rank Across All Funds🌏Country
13🇺🇸United States
💳ARK Estimated Cost Average🎫ARK Ownership Percent
$53.266.59%
Description
Intellia Therapeutics is a leading clinical-stage genome editing company, focused on the development of proprietary, potentially curative therapeutics using the CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology has the potential to transform medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creating enhanced engineered cells that can treat oncological and immunological diseases. Intellia's combination of deep scientific, technical and clinical development experience, along with its leading intellectual property portfolio, puts it in a unique position to unlock broad therapeutic applications of the CRISPR/Cas9 technology and create new classes of therapeutic products.
Website
www.intelliatx.com